BioCentury
ARTICLE | Clinical News

Trerief: Ph III data

April 12, 2017 12:34 AM UTC

Top-line data from the modified intent-to-treat (mITT) population of a double-blind, Japanese Phase III trial in 351 patients with Parkinsonism accompanying dementia with Lewy bodies showed that once-...

BCIQ Company Profiles

Sumitomo Pharma Co. Ltd.

BCIQ Target Profiles

Calcium channel